Review Article
Volume 9 Issue 11 - 2020
Management of Critical Cases of COVID-19 Infection
Khaled Mohamed Elsharkawy1*, Ziyad Naser AlGhamdi2, Naif Matar Alotaibi3, Jamal Sharaf Alzahrani4, Bashayer Mousa Aseeri5, Uthman Abdullah Alghamdi3, Khalid A ALNouri6, Raghad Adel Alrowithi7, Rawan Asim Zagzoog8, Sultan Sameer Alhunbusi9 and Lujain Hani Natto8
1Critical Care Specialist, King Abdulaziz Hospital, Jeddah, Saudi Arabia
2King Abdulaziz Hospital, Jeddah, Saudi Arabia
3Prince Sultan Military Medical City, Riyadh, Saudi Arabia
4King Abdulaziz Hospital, Mecca, Saudi Arabia
5King Saud bin Abdulaziz for Health Sciences, Riyadh, Saudi Arabia
6King Abdulaziz University Hospital, Jeddah, Saudi Arabia
7Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia
8Alnoor Specialist Hospital, Mecca, Saudi Arabia
9King Abdulaziz Specialist Hospital, Taif, Saudi Arabia
*Corresponding Author: Khaled Mohamed Elsharkawy, Critical Care Specialist, King Abdulaziz Hospital, Jeddah, Saudi Arabia
Received: October 02, 2020; Published: October 19, 2020




Abstract

Background: Coronavirus disease 2019 (COVID-19) is the third coronavirus infection in two decades that was eventually described in Asia, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).

Aim: In this review, we will look into the epidemiology, clinical manifestation of severe cases, and management of critical cases of COVID-19 infection.

Conclusion: More research should be conducted in area of critical management of COVID-19 cases to decrease mortality rate as the virus continues to spread. Up-to-date, evidence-based recommendations for acute treatment of COVID-19 are important to steer clinicians in a rapidly emerging pandemic. When fresh research arises, it is important those existing and future therapeutic choices are constantly re-evaluated in order to ensure the best available service in such extraordinary circumstances.

Key words: COVID-19 Viral Infection; Management Severe Cases of COVID-19; Symptoms of Severe Cases of COVID-19; Corona Virus Management

References

  1. Morens David M., et al. “Escaping Pandora’s Box - Another Novel Coronaviru”. New England Journal of Medicine (2020): 1293-1295.
  2. World Health Organization. Director-General's remarks at the media briefing on 2019-nCoV (2020).
  3. Gorbalenya AE., et al. “Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group”. Bio Rxiv (2020).
  4. Shuaiyao Lu., et al. “Comparison of nonhuman primates identified the suitable model for COVID-19”. Signal Transduction and Targeted Therapy 5 (2020): 1.
  5. WHO found (2019).
  6. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet10223 (2020): 507-513.
  7. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]”. Zhonghua Liu Xing Bing Xue Za Zhi2 (2020): 145-151.
  8. Zhou F., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet10229 (2020): 1038.
  9. Colaneri M., et al. “Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy 21 to 28 February 2020”. Eurosurveillance 16 (2020).
  10. Docherty AB., et al. “Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study”. British Medical Journal (2020).
  11. CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12 - March 16, 2020”. Morbidity and Mortality Weekly Report (2020).
  12. Mehta NS., et al. “SARS-CoV-2 (COVID-19): what do we know about children? A systematic review”. Clinical Infectious Diseases (2020).
  13. Posfay-Barbe KM., et al. “COVID-19 in children and the dynamics of infection in families”. Pediatrics2 (2020): e20201576.
  14. Castagnoli R., et al. “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review”. JAMA Pediatrics (2020).
  15. https://www.worldometers.info/corona
  16. Mark Honigsbaum and Pierre-Olivier Méthot. “Introduction: microbes, networks, knowledge-disease ecology and emerging infectious diseases in time of COVID-19”. History and Philosophy of the Life Sciences 42 (2020): 3.
  17. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series”. British Medical Journal 368 (2020): m792.
  18. Guan WJ., et al. “Clinical characteristics of 2019 novel coronavirus infection in China”. Med Rxiv (2020).
  19. Zhang JJ., et al. “Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China”. Allergy (2020): 1730-1741.
  20. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. The Journal of the American Medical Association (2020).
  21. De Wit E., et al. “SARS and MERS: recent insights into emerging coronaviruses”. Nature Reviews Microbiology 8 (2016): 523-534.
  22. Zumla A., et al. “Middle East respiratory syndrome”. Lancet 386 (2015): 995-1007.
  23. Al-Omari A., et al. “MERS coronavirus outbreak: Implications for emerging viral infections”. Diagnostic Microbiology and Infectious Disease 3 (2019): 265-285.
  24. Yeung ML., et al. “MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2”. Yuen KYNat Microbiology 1 (2016):16004.
  25. Aleksandar Milenkovic., et al. “Extensions and adaptations of existing medical information system in order to reduce social contacts during COVID-19 pandemic”. International Journal of Medical Informatics 141 (2020): 104224.
  26. Zhongliang Wang., et al. “Household transmission of SARS-CoV-2”. Journal of Infection1 (2020): 179-182.
  27. David M Morens and Anthony S Fauci. “Emerging Pandemic Diseases: How We Got to COVID-19”. Cell (2020).
  28. Loma Linda University, Loma Linda, CA.
  29. Valentin Navel., et al. “COVID ‐19, sweat, tears… and myopia?”. Clinical and Experimental Optometry4 (2020): 555-555.
  30. Yang X., et al. “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study”. The Lancet Respiratory Medicine (2020).
  31. Moriguchi T., et al. “A first case of meningitis/encephalitis associated with SARS-coronavirus-2”. International Journal of Infectious Diseases 94 (2020): 55-58.
  32. Wu Y., et al. “Nervous system involvement after infection with COVID-19 and other coronaviruses”. Brain, Behavior, and Immunity 87 (2020): 18-22.
  33. Gu J., et al. “COVID-19: gastrointestinal manifestations and potential fecal–oral transmission”. Gastroenterology 158 (2020): 1518-1519.
  34. Wei jie guan Clinical characteristics of coronavirus disease 2019 in China”. The New England Journal of Medicine (2020).
  35. Khai Tran., et al. “Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review”. PLoS One 4 (2012): e35797.
  36. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients”. The Canadian Journal of Anesthesia (2020).
  37. Michael A Matthay., et al. “Treatment for severe acute respiratory distress syndrome from COVID-19”. The Lancet Respiratory Medicine 5 (2020): 433-434.
  38. Kollengode Ramanathan., et al. “Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases”. The Lancet Respiratory Medicine (2020).
  39. Xiaochun Ma., et al. “Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation”. The Journal of the American Medical Association (2020): e925364-1–e925364-10.
  40. Prof Chaolin Huang., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 497-506.
  41. Jianfeng Xie., et al. “Critical care crisis and some recommendations during the COVID-19 epidemic in China”. Intensive Care Medicine (2020): 1-4.
  42. Prof Nanshan Chen., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet 395 (2020): 507-513.
  43. Qiurong Ruan., et al. “Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China”. Intensive Care Medicine 5 (2020): 846-848.
  44. Xia S., et al. “Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion”. Cell Research 4 (2020): 343-355.
  45. Coronavirus disease 2019 (COVID-19) Centers for Disease Control and Prevention (2020).
  46. Grein J., et al. “Compassionate Use of Remdesivir for Patients with Severe Covid-19”. The New England Journal of Medicine 24 (2020): 2327-2336.
  47. Wang M., et al. “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) In vitro”. Cell Research 3 (2020): 269-271.
  48. Gautret P., et al. “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”. The International Journal of Antimicrobial Agents 1 (2020): 105949.
  49. Marchand-Senécal X., et al. “Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS”. Clinical Infectious Diseases (2020): ciaa227.
  50. Starting, reviewing and stopping critical care treatment | COVID-19 rapid guideline: critical care in adults | Guidance | NICE (2020).
  51. Chris R Triggle., et al. “COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions”. M Sphere 5 (2020): 3.
Citation: Khaled Mohamed Elsharkawy., et al. “Management of Critical Cases of COVID-19 Infection”. EC Gynaecology 9.11 (2020): 38-44.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.